New Clinical Trial for Pazopanib Offers Hope for HHT Patients

New Clinical Trial for Pazopanib Offers Hope for HHT Patients

In a groundbreaking development for the treatment of Hereditary Hemorrhagic Telangiectasia (HHT), a rare and life-threatening vascular disorder, nonprofit organization cureHHT has officially launched a Phase II/III clinical trial for the drug pazopanib. This...

Study shows how to prevent a high-fat diet from throwing metabolism out of whack

Study shows how to prevent a high-fat diet from throwing metabolism out of whack

Eating lots of fats increases the risk of metabolic disorders, but the mechanisms behind the problem have not been well understood. Now, University of California, Irvine biologists have made a key finding about how to ward off harmful effects caused by a high-fat diet. Their study appears in Nature Communications.